Family Screening And Surveillance Strategies In Loeys-Dietz Syndrome
Published on: November 21, 2025
Family Screening And Surveillance Strategies In Loeys-Dietz Syndrome
  • Article author photo

    Chloe Donkin

    Bachelor of Science - Biomedical Sciences, University of Dundee, Scotland

  • Article reviewer photo

    Esha Mepani

    Bachelor of Science in Biomedical Sciences

Introduction

Loeys-Dietz Syndrome (LDS) is a genetic disorder caused by mutations in specific genes. Children may inherit the condition from a parent carrying one of these mutated genes.1,2 There are lots of LDS symptoms that can show up throughout the body, with Aortic Aneurysms being a typical feature of the disease.3,4 This makes LDS a life-threatening and difficult disease to live with, so it must be monitored closely.3 Family screening and surveillance strategies play a critical role in identifying at-risk relatives and managing symptoms to prevent disease progression.3,5

What causes loeys-dietz syndrome

Genes are small sections of DNA that are the instructions for a specific characteristic or protein.6 They are passed down from parents to children, and they determine how we grow, develop and function.6 Occasionally, genes undergo random, spontaneous changes known as mutations, which can lead to genetic disorders.2 Loeys-Dietz Syndrome (LDS) is an example of a genetic disorder caused by mutations.1,7 It is an autosomal dominant genetic disorder, which means that it is caused by mutated genes that can be passed down from one parent who carries the faulty gene.2,8 If one parent has Loeys-Dietz Syndrome, each of their children has a 50% chance of inheriting the condition.2 As genetic mutations occur randomly, no one is at fault for causing the condition.

The mutated genes that cause LDS often negatively affect the Transforming Growth Factor beta  (TGF-β) pathway.4 TGF-β is a protein that is produced by almost every tissue and cell type.9 It is incredibly prominent in the animal kingdom and has been evolutionarily conserved.10 This means that it has been passed down throughout generations with minimal changes to the structure and function of the protein. When cells release TGF-β, it interacts with others, triggering responses such as growth, metabolism, cell replication, and differentiation (where cells specialise into specific roles).9,10 Proper TGF-β signalling is therefore vital for normal development and tissue function.9,10

Mutations disrupt this pathway, causing health problems as our tissues and organs cannot function properly, leading to the symptoms of LDS.1,9 There are five primary gene mutations linked to inherited LDS.4,11 The severity of the condition varies by mutation type, with LDS Type 1 being the mildest and LDS Type 5 the most severe.11 

Type of LDSGene MutationSeverity
Type 111Mutation in the TGF-β Receptor 1 protein4,11Least Severe Symptoms4,11
Type 211Mutation in the TGF-β Receptor 2 protein4,11Less Severe than Type 3, More Severe than Type 14,11
Type 311Mutation in the Mothers Against Decapentaplegic Homology 3 (SMAD3) protein4,11Less Severe than Type 4, More Severe than Type 24,11
Type 411Mutation in the TGF-β2 protein4,11Less Severe than Type 5, More Severe than Type 34,11
Type 511Mutation in the TGF-β3 protein4,11Most Severe Symptoms4,11

Symptoms and clinical features of LDS

Loeys-Dietz Syndrome (LDS) disrupts normal development, affecting multiple tissues and organs throughout the body.3, 1 Because it is not restricted to one area, it is said to have ‘multisystem involvement.4,8 Common areas affected include the cardiovascular system (heart and blood vessels), bones, skin, connective tissues, and internal organs such as the intestines. Additionally, individuals with LDS may have an increased risk of allergies.3

Due to there being so many symptoms of LDS, it can be hard to identify the disease.3 The key characteristics that a doctor may look for when diagnosing LDS include:

  1. Aneurysms3,12 - Abnormal widening of arteries (blood vessels carrying oxygen-rich blood from the heart).13,14 In LDS, this is often seen at the root of the aorta, the large artery that is connected to your heart.3,4 If untreated, they can rupture, leading to life-threatening complications15
  2. Arterial Tortuosity3,4,12 - The twisting and turning of arteries, which can prevent blood flow to other organs16
  3. Hypertelorism of the Eyes3,12 - A medical term that describes an abnormally large distance between the eyes17
  4. Bifid Uvula3,12 - A mild version of cleft palate, where the small hanging bit of tissue at the back of the throat is split or forked18

Not all individuals with LDS will exhibit these features, and their severity can differ significantly.3,11 Importantly, these signs alone do not confirm LDS; a thorough clinical evaluation, including genetic testing, is essential for diagnosis3,11

Other symptoms and features that may make a doctor suspect LDS are detailed in the table below:

Part of the Body AffectedPossible Symptoms or Features
Heart and Blood Vessels (Cardiovascular System)Aortic Aneurysm, Arterial Tortuosity, Arterial dissection (tears in the walls of arteries), Arterial dilation (widening of the arteries), irregular heartbeats (Heart Arrhythmias), congenital heart defects3,4
Bones (Skeletal System or Orthopedics)Deformities of the chest wall (Pectus), Scoliosis, flat feet, bone overgrowth, overly flexible joints, joints with limited ranges of motion, abnormally long or slender fingers (Arachnodactyly), Clubfoot, Osteoarthritis3,4
Skull and Face (Craniofacial)Abnormally wide distance between the eyes (Hypertelorism), Improper growth of a baby’s skull due to soft spots of bone fusing together too early (Craniosynostosis), a wide or split Uvula (Bifid Uvula)3
Skin (Cutaneous)Soft, velvety skin, translucent skin that allows you to see veins underneath, skin that bruises and scars easily, the presence of small white or yellowish spots that appear on the face known as Milia3
Predisposition to Developing AllergiesIncreased risk of developing food allergies, seasonal allergies, Asthma, Chronic Sinusitis, Eczema, abnormally high amounts of white blood cells known as eosinophils in the digestive tract (Eosinophilic esophagitis or gastritis), Inflammatory Bowel Disease3
EyesPresence of a blue or dusky sclera (the whites of the eyeball)3

Table detailing the clinical features of Loeys-Dietz Syndrome created by Chloe Donkin

LDS shares several clinical features with other connective tissue disorders, particularly Marfan syndrome and vascular Ehlers-Danlos syndrome. Due to this symptom overlap, doctors typically confirm a diagnosis through genetic testing.3,8

Genetic testing for LDS

Genetic testing for LDS involves analysing a small sample of blood or saliva in a specialist laboratory. Scientists examine the DNA for known disease-causing mutations in genes associated with LDS. This testing provides a conclusive diagnosis when clinical symptoms alone are insufficient for differentiation from other connective tissue disorders.19

Following a positive test result, patients are referred to a geneticcounsellor.3.4 Genetic counsellors are professionals who can read a genetic test and tell you what this means for you or for your family.19 They can also direct you to appropriate resources or support groups, and they can liaise with other medical specialists to organise treatment.4,19 This is especially important in LDS because it can affect so many parts of your body, meaning that you may be treated by multiple experts in different medical disciplines.

For prospective parents, genetic testing can be performed during pregnancy through chorionic villus sampling or amniocentesis. Alternatively, preimplantation genetic diagnosis is available for couples undergoing IVF treatment. These options allow families to make informed reproductive choices and understand the risks of passing the condition to future children.3

Non-genetic tests for LDS

If genetic tests are not conclusive enough, non-genetic tests for LDS may also be done. This includes:

  • Physical examinations performed by a doctor to look for features of LDS3
  • Echocardiograms3 -  This is a type of scan that is used to look at the heart structure, function and surrounding blood vessels20
  • Other imaging techniques like Computerised Tomography (CT) scans or Magnetic Resonance (MR) Angiograms are used to look at all of your blood vessels to identify twisted arteries or aneurysms3,4

The importance of family screening

Because LDS is an inherited genetic disorder, family screening plays a crucial role in identifying at-risk relatives. This process enables healthcare professionals to test family members for the same genetic mutations, helping to assess potential health risks for both themselves and future generations.3 It can also help to guide management of your health conditions.11,19

Who should be screened?

  • First-degree relatives like your children, your siblings and your parents3
  • If a harmful genetic mutation is found, the extended family may also need to be screened3,19

When to start screening?

Screening can be performed at any age, but is most effective when initiated early. For children with a family history of LDS, evaluation should begin in infancy or early childhood to monitor for emerging symptoms and implement preventive care as needed. Regular follow-ups are recommended to track any changes over time.3

This structured approach ensures that affected individuals and their families receive appropriate surveillance and care, reducing the risk of serious complications associated with LDS.

How is LDS monitored?

Following a confirmed LDS diagnosis through genetic testing, a comprehensive surveillance plan is implemented to monitor disease progression and prevent complications.3,4 This usually includes:

  • Regular Echocardiograms are used to look at and monitor the status of the aorta3,20
  • Extensive vascular imaging techniques like Computerised Tomography (CT)  or Magnetic Resonance (MR) angiograms look at all of your blood vessels for twisted arteries or aneurysms3,4
  • Regular doctor's visits are also used to check up on people with other symptoms. This is especially important in making sure that these symptoms do not get worse3

Doctors may also advise you to avoid extreme sports, avoid agents that stimulate your heart and avoid activities that cause joint pain3 

During pregnancy, surveillance intensifies due to the increased risk of cardiovascular complications. More frequent monitoring is essential to ensure maternal and fetal well-being throughout gestation.3,4

Summary

  • Loeys-Dietz Syndrome is an inherited connective tissue disorder caused by mutations in genes affecting the TGF-β signaling pathway. This autosomal dominant condition shows variable expressivity, meaning symptom severity depends on the specific genetic mutation involved and can range from mild (Type 1) to severe (Type 5) presentations
  • LDS causes a wide range of symptoms and can affect many parts of the body. The main symptoms that a doctor will look for are aortic aneurysms, arterial tortuosity, hypertelorism of the eyes and a bifid uvula
  • Doctors will use saliva or blood samples to confirm an LDS diagnosis with genetic tests. These tests can identify gene mutations associated with the condition. This allows doctors to put monitoring and management plans in place to avoid problems
  • As LDS is an inherited condition. Family members should also be tested for LDS to help catch issues early and guide treatment
  • Important management considerations include:
    • Activity restrictions (avoiding contact sports/isometric exercise)
    • Cardiovascular risk reduction strategies
    • Enhanced pregnancy surveillance (due to increased complication risks)
    • Individualised surgical planning when interventions become necessary

References

  1. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nature Genetics [Internet]. 2005 Jan 30 [cited 2025 Jul 15];37:275–81. Available from: https://doi.org/10.1038/ng1511 
  2. Hanchard N. Autosomal Dominant Disorder [Internet]. Genome.gov. 2022 [cited 2025 Jul 17]. Available from: https://www.genome.gov/genetics-glossary/Autosomal-Dominant-Disorder 
  3. Loeys BL, Dietz HC. Loeys-Dietz Syndrome. GeneReviews [Internet]. 2008 Feb 28 [cited 2025 Jul 15]; Available from: https://pubmed.ncbi.nlm.nih.gov/20301312 
  4. MacCarrick G, Black JH, Bowdin S, El-Hamamsy I, Frischmeyer-Guerreio PA, Guerreio AL, et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genetics in Medicine [Internet]. 2014 Aug [cited 2025 Jul 15];16(8):576–87. Available from: https://doi.org/10.1038/gim.2014.11 
  5. NHS website. Genetic and genomic testing [Internet]. nhs.uk. 2019 [cited 2025 Jul 18]. Available from: https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/ 
  6. Definition of gene - NCI Dictionary of Cancer Terms [Internet]. National Cancer Institute. 2012 [cited 2025 Jul 18]. Available from: https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/gene 
  7. Gilchrist DA. Mutation [Internet]. National Human Genome research institute. National Human Genome Research Institute; 2019 [cited 2025 Jul 18]. Available from: https://www.genome.gov/genetics-glossary/Mutation 
  8. Van Laer L, Proost D, Loeys BL. Educational Paper - Connective tissue disorders with vascular involvement: from gene to therapy. European Journal of Pediatrics [Internet]. 2012 Jul 17 [cited 2025 Jul 17];172:997–1005. Available from: https://doi.org/10.1007/s00431-012-1773-x 
  9. Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-β signalling in health, disease and therapeutics. Signal Transduction and Targeted Therapy [Internet]. 2024 Mar 22 [cited 2025 Jul 18];61. Available from: https://doi.org/10.1038/s41392-024-01764-w  
  10. Tzavlaki K, Moustakas A. TGF-β Signalling. Biomolecules [Internet]. 2020 Mar 23 [cited 2025 Jul 15];10(3). Available from: https://doi.org/10.3390/biom10030487 
  11. Gouda P, Kay R, Habib M, Aziz A, Aziza E, Welsh R. Clinical features and complications of Loeys-Dietz syndrome: A systematic review. International Journal of Cardiology [Internet]. 2022 Sep 1 [cited 2025 Jul 15];362:158–67. Available from: https://doi.org/10.1016/j.ijcard.2022.05.065 
  12. Hughes GC. Aggressive Aortic Replacement for Loeys-Dietz Syndrome. The Texas Heart Institute Journal [Internet]. 2011 [cited 2025 Jul 18];38(6):663–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3233316/ 
  13. Mercadante AA, Raja A. Anatomy, Arteries. StatPearls [Internet]. 2023 Mar 6 [cited 2025 Jul 18]; Available from: https://pubmed.ncbi.nlm.nih.gov/31613523 
  14. National Cancer Institute. Classification & Structure of Blood Vessels [Internet]. NIH. 2019. Available from: https://training.seer.cancer.gov/anatomy/cardiovascular/blood/classification.html 
  15. Du T, Wang W, Wang Y, Liu K. Research Progress on Aortic Root Aneurysms. Medical Science Monitor [Internet]. 2024 Feb 9 [cited 2025 Jul 18]; Available from: https://doi.org/10.12659/MSM.943216  
  16. Han HC. Twisted Blood Vessels: Symptoms, Eitology and Biomechanical Mechanisms. Journal of Vascular Research [Internet]. 2012 Mar 14 [cited 2025 Jul 18];49(3):185–97. Available from: https://doi.org/10.1159/000335123 
  17. Tripathy K, Ghosh D. Hypertelorism. StatPearls [Internet]. 2025 Apr 19 [cited 2025 Jul 18]; Available from: https://pubmed.ncbi.nlm.nih.gov/32809540 
  18. Prasad P, Khalil E, Desai VB, Varma SR, Gunasekaran L, Kumar K, et al. Bifid Uvula- An Enigma. Journal of Pharmacy & BioAllied Sciences [Internet]. 2023 Jul 5 [cited 2025 Jul 18];15(Supplement 1):S806–9. Available from: https://doi.org/10.4103/jpbs.jpbs_464_22 
  19. NHS website. Genetic and genomic testing [Internet]. nhs.uk. 2019 [cited 2025 Jul 18]. Available from: https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/ 
  20. NHS website. Echocardiogram [Internet]. nhs.uk. 2017 [cited 2025 Jul 18]. Available from: https://www.nhs.uk/tests-and-treatments/echocardiogram/ 
Share

Chloe Donkin

Bachelor of Science - Biomedical Sciences, University of Dundee, Scotland

Chloe graduated with her BSc in Biomedical Sciences from the University of Dundee in 2025. She has a keen interest in the immune system and how it works to protect us from disease. She hopes to convey this passion in her work at Klarity. She will be starting her PhD in autumn 2025.

arrow-right